~~<i id='BCC0078E9B'><strike id='BCC0078E9B'><tt id='BCC0078E9B'><pre id='BCC0078E9B'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

focus

author：leisure time 2025-09-27 22:46:03 - browse：8317

People taking notes while sitting around a meeting table — Adobe

It makes sense in theory for hospitals and startups to strike deals. Not only would doctors get first dibs on new health care technologies, their organizations would see windfalls if those startups hit it big.

In practice, it often doesn’t work out that way. Doctors and other clinicians have their own way of doing things, and they typically don’t take kindly to an administrator telling them to learn a new product, especially if the goal is financial gain.

Several health system-venture capital arrangements have fallen victim to this dynamic — but VC firm General Catalyst said this week it will buy nonprofit Summa Health, anyway.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Heart attack and stroke risk calculators need revising
Next article： Coercive sterilizations revealed by STAT prompt outrage

focus

knowledge

entertainment

hotspot

leisure time

KimKardashiantoutedfull-bodyMRIscansinarecentInstagrampost.AshleyLandis/APThelasttimeKimKardashianpo

WSS

STAT Virtual Event: ASCO Recap, Live!

Stephen Quake on the Chan Zuckerberg quest to conquer disease

White House drug shortages task force keeps mum with Congress

Iran moves toward freeing 5 American citizens who had been imprisoned, in rare deal

Listen: Your guide to Wegovy's blockbuster heart study

Genentech weighs delaying cancer therapy after drug pricing law

focus

focus

focus

Sports medicine is finally prioritizing gender equality

Faced with fears of OxyContin misuse, sales reps touted its safety

Apple is now the first public company to be valued at $3 trillion

GOP presidential candidates start declaring their loyalty

Medical records are filled with copy

How the BIOSECURE Act is already affecting U.S., Chinese life science firms

FDA approval of Sarepta Duchenne genetic therapy gives me hope

TB outbreak tied to bone grafts underscores testing shortcomings

After affirmative action ruling, medical educators look to 'holistic review'

GOP presidential candidates start declaring their loyalty

knowledge

Teladoc has a new CEO, but challenges remain the same

Study: Why relieving medical debt did not improve financial outcomes

NYC stabbing: Teen named, arraigned by District Attorney in O'Shae Sibley death

STAT Virtual Event: ASCO Recap, Live!

Curing rare childhood diseases will falter unless Congress steps up

Study: Why relieving medical debt did not improve financial outcomes

entertainment

hotspot

hotspot

leisure time